Developing regions vs Nepal: Proportion of the target population who received a 3rd dose of
Developing regions
66.0%
in 2024
Nepal
96.0%
in 2024
Developing regions rank
12th
Nepal rank
15th
Proportion of the target population who received a 3rd dose of over time
- Developing regions
- Nepal
How they compare
Nepal currently reports 96.0% against 66.0% in Developing regions, a difference of 30.0%.
That makes Nepal's figure about 1.5 times Developing regions's.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Developing regions ahead.
Developing regions ranks 12th and Nepal ranks 15th of 19 groups.
Nepal has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Developing regions | Nepal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 41.0% | 59.2% | 18.2% | Nepal |
| 2020s | 56.4% | 86.2% | 29.8% | Nepal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Developing regions or Nepal?
- Nepal, at 96.0% against 66.0% in Developing regions as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Developing regions and Nepal?
- 30.0%, with Nepal ahead.
- How many years of comparable data are there for Developing regions and Nepal?
- 10 years are reported by both, from 2015 to 2024.
- How do Developing regions and Nepal rank globally for proportion of the target population who received a 3rd dose of?
- Developing regions ranks 12th and Nepal ranks 15th of 19 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.